Andere Sprachen Zynex, Inc.

Aktien

Realtime-Estimate Cboe BZX Andere Börsenplätze 19:22:28 29.04.2024			% 5 Tage	% 1. Jan.
11,43 ^USD	+1,96 %		+2,69 %	+5,05 %

01.03.	ZYNEX, INC. : erhält Kaufen-Rating von RBC Capital Markets	ZM
29.02.	Zynex, Inc. gibt Gewinnprognose für das erste Quartal und das Gesamtjahr 2024	CI

Zynex Sets First Quarter 2024 Earnings Call	18.04.
Zynex Earns Prestigious 2024 Top Workplaces USA Employer Recognition Award	02.04.
Zynex Reports Fourth Quarter and Full Year 2023 Financial Results	01.03.
Zynex, Inc. Provides Earnings Guidance First Quarter and Full Year 2024	29.02.
Tranche Update on Zynex, Inc.'s Equity Buyback Plan announced on September 11, 2023.	29.02.
Tranche Update on Zynex, Inc.'s Equity Buyback Plan announced on November 1, 2023.	29.02.
Zynex, Inc. announces an Equity Buyback for $20 million worth of its shares.	29.02.
Earnings Flash (ZYXI) ZYNEX Reports Q4 Revenue $47.3M, vs. Street Est of $55.6M	29.02.
Zynex, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	29.02.
Zynex, Inc. authorizes a Buyback Plan.	29.02.
Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call	22.02.
Zynex Introduces New Products	20.02.
Zynex, Inc. Introduces New Products	20.02.
Zynex Receives FDA Clearance for its Next Generation NMES Device	07.02.
Zynex Receives US FDA Approval for Muscle Stimulation Device	06.02.
Zynex, Inc. Receives FDA Clearance for its Next Generation NMES Device	06.02.
Zynex Recognized in Top 25 Medical Device Companies for 2024	02.02.
Zynex to Participate at the Needham Annual Growth Conference	08.01.
Zynex, Inc.'s Equity Buyback announced on September 11, 2023, has closed with 1,161,536 shares, representing 3.3% for $10 million.	31.12.
Zynex Ranked in Forbes List of 'America's Most Successful Small-Cap Companies 2024'	16.11.

Keine Ergebnisse zu dieser Suche